Multifaceted Efforts from Basic Research to Clinical Practice in Controlling COVID-19 Disease

Dear Colleagues,

COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been around for over two years, representing the longest viral pandemic in history. Efforts to end or to reduce the short- or long-term adverse effects of the disease are multifaceted, including on-site quantitative viral assay, virus variant monitoring, multivalent vaccine development, drug discovery targeting viral replication and/or translation machinery, psychiatric treatment and counseling, antiviral and anti-inflammatory dual therapy, comorbidity control, and care for residual symptoms or syndrome. This Topic is intended to gather research articles, full reviews, and mini reviews touching upon the efforts listed above. We welcome any manuscript describing basic research and/or its translation to field or clinical practice in the multidisciplinary areas of SARS-CoV-2 assay and variant monitoring, multivalent vaccine development and drug targeting viral replication and/or translation machinery, psychiatric treatment and counseling, antiviral and anti-inflammatory dual therapy, comorbidity reduction, and care for residual diseases after viral eradication.

Dr. Yih-Horng Shiao
Dr. Rashi Ojha
Topic Editors